News & Press

Soleno Therapeutics Engages FLG Partners

09/05/17

September 5, 2017 – Soleno Therapeutics Inc. (NASDAQ CM: SLNO) announced today that it has engaged FLG Partners for interim CFO services. Company Form 8-K. FLG partner: Jonathan Wolter.